EUVIMEDEUVIMED entdecken
Crossref

Longitudinal Changes in Exocrine Biomarkers in Children at Risk of Type 1 Diabetes in the ENDIA Study

Madeleine Hall, Megan A S Penno iD, Timothy Spelman, Rhonda Bacher, James D Brown, Wayne A Rankin, Dao Huynh iD, Elizabeth A Davis iD, Maria E Craig iD, Tony Huynh, John M Wentworth iD, Fergus J Cameron iD und 7 weitere

Diabetes Care · 02.11.2026

DOI: 10.2337/dc26-1627 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes Care, online erschienen am 02.11.2026. Verfasst von Madeleine Hall und 18 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, College of Health and Robinson Research Institute, Adelaide University, Adelaide, South Australia, Australia. Gefördert von: Leona M. and Harry B. Helmsley Charitable Trust, Breakthrough T1D.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE The exocrine pancreas is increasingly implicated in type 1 diabetes. Noninvasive biomarkers of exocrine function, fecal elastase-1 (FE-1) and serum immunoreactive trypsin (IRT), may provide early insight into disease pathogenesis. We investigated the temporal relationship between exocrine biomarkers and type 1 diabetes development in children. RESEARCH DESIGN AND METHODS FE-1 and IRT concentrations were measured prospectively in 301 at-risk children followed in the Environmental Determinants of Islet Autoimmunity (ENDIA) cohort from birth. A total of 216 children provided 1,679 stool samples; 242 provided 1,014 serum samples. Biomarker trajectories were compared between children who developed islet autoimmunity or type 1 diabetes and age- and sex-matched control children negative for autoantibodies in a nested case-control design. Adjusted linear mixed models were used. RESULTS Two biomarker patterns were observed. FE-1 concentrations were lower during the first 6 months of life in children who subsequently developed multiple islet autoantibodies or type 1 diabetes (β-coefficient at birth −0.61 [95% CI −1.04, −0.17]; P = 0.006; β-coefficient at 3 months −0.39 [95% CI −0.69, −0.09]; P = 0.010); IRT concentrations were lower in children who developed type 1 diabetes 12 months (β = −0.30 [95% CI −0.58, −0.02]; P = 0.034) and 18 months (β = −0.40 [95% CI −0.71, −0.10]; P = 0.008) before type 1 diabetes diagnosis. CONCLUSIONS Changes in exocrine biomarkers were detectable early in the natural history of type 1 diabetes, with a delayed rise of FE-1 in infants who later progressed to multiple islet autoantibodies or type 1 diabetes and a decrease in IRT following islet autoantibody seroconversion.

Autor:innen und Institutionen

  • School of Medicine, College of Health and Robinson Research Institute, Adelaide University, Adelaide, South Australia, Australia.
  • Department of Diabetes and Endocrinology, Women's and Children's Hospital, Adelaide, South Australia, Australia.
  • Diabetes Institute, University of Florida, Gainesville, FL.
  • Department of Biostatistics, College of Medicine, University of Florida, Gainesville, FL.
  • Chemical Pathology Directorate, SA Pathology, Adelaide, South Australia, Australia.
  • Endocrine and Metabolic Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia.

ORCID-Profile: Megan A S Penno, Dao Huynh, Elizabeth A Davis, Maria E Craig, John M Wentworth, Fergus J Cameron, Clive H Wasserfall, Jennifer J Couper

Förderung

  • Leona M. and Harry B. Helmsley Charitable Trust
  • Breakthrough T1D

Zitieren

APA

Hall, M., Penno, M. A. S., Spelman, T., Bacher, R., Brown, J. D., Rankin, W. A., Huynh, D., Davis, E. A., Craig, M. E., Huynh, T., Wentworth, J. M., Cameron, F. J., Soldatos, G., Vuillermin, P. J., Atkinson, M. A., Campbell-Thompson, M. L., Wasserfall, C. H., Couper, J. J., & ENDIA Study Group* (2026). Longitudinal Changes in Exocrine Biomarkers in Children at Risk of Type 1 Diabetes in the ENDIA Study. Diabetes Care. https://doi.org/10.2337/dc26-1627

Vancouver

Hall M, Penno MAS, Spelman T, Bacher R, Brown JD, Rankin WA, et al. Longitudinal Changes in Exocrine Biomarkers in Children at Risk of Type 1 Diabetes in the ENDIA Study. Diabetes Care. 2026. doi:10.2337/dc26-1627

BibTeX
@article{Hall2026,
  author = {Hall, Madeleine and Penno, Megan A S and Spelman, Timothy and Bacher, Rhonda and Brown, James D and Rankin, Wayne A and Huynh, Dao and Davis, Elizabeth A and Craig, Maria E and Huynh, Tony and Wentworth, John M and Cameron, Fergus J and Soldatos, Georgia and Vuillermin, Peter J and Atkinson, Mark A and Campbell-Thompson, Martha L and Wasserfall, Clive H and Couper, Jennifer J and ENDIA Study Group*, ENDIA Study Group*},
  title = {Longitudinal Changes in Exocrine Biomarkers in Children at Risk of Type 1 Diabetes in the ENDIA Study},
  journal = {Diabetes Care},
  year = {2026},
  doi = {10.2337/dc26-1627}
}
Kostenlos starten →